CN1121810A - Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof - Google Patents
Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof Download PDFInfo
- Publication number
- CN1121810A CN1121810A CN 93121565 CN93121565A CN1121810A CN 1121810 A CN1121810 A CN 1121810A CN 93121565 CN93121565 CN 93121565 CN 93121565 A CN93121565 A CN 93121565A CN 1121810 A CN1121810 A CN 1121810A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- medicine preparation
- rhizoma
- osteoporosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese-medicinal compound preparation for curing osteoporosis with high curative effect, low cost and no toxicity is prepared from cnidium fruit, epimedium and pearl powder. The 10 prescriptions are disclosed for curing osteoporosis caused by different reasons such as primary one, menopause, senility, hypercorticism, hyper thyroidism, diabetes mellitus, etc.
Description
The present invention relates to treat the compound Chinese medicinal preparation and the method for making thereof of osteoporosis.
Osteoporosis is one of important diseases of harm humans health, aging along with population, the patient of primary osteoporosis is increasing, research has recently confirmed that also a lot of diseases also can cause secondary osteoporosis, particularly the multiple diseases such as renal osteodystrophy due to diabetes, disease of parathyroid glands, hyperthyroidism, chronic glomerulonephritis, the chronic pyelonephritis etc. all can cause osteoporosis, in addition, medicine is the prolonged application adrenocortical hormone particularly, the anticancer chemotherapy medicine, retinoic acid etc. also can cause serious osteoporosis.Therefore, prevention and treatment of osteoporosis becomes an important topic that urgency is to be solved.
Task of the present invention is a kind of compound preparation of being made up of pure Chinese medicine of development, and said preparation can stop further losing of sclerotin, can promote the formation of new bone again, and the osteoporosis due to a variety of causes is all had certain preventive effect and therapeutical effect.This subject study person has proved that a kind of composition that extracts has the effect of good protect against osteoporosis (seeing Chinese patent application 92105338.X) from the Chinese medicine Fructus Cnidii, Fructus Cnidii and other Chinese medicine have further been studies have shown that, the compound preparation formed of Herba Epimedii and Margarita layer powder particularly, osteoporosis to several animal models all has good preventive and therapeutic effect, provides new approach for solving the osteoporosis problem of preventing and treating.
The approach that solves this task is achieved in that gets the Chinese medicine Fructus Cnidii, and Herba Epimedii and Margarita layer powder three combine, and forms compound recipe, is made into Chinese medicinal tablet by following technology, and electuary or capsule are for clinical practice.Studies show that this preparation is to removal ovary, go the experimental osteoporosis due to the testis,, insufficiency of kidney-YANG osteoporosis due to the chemotherapeutic hydroxyurea etc. is all had good preventive and therapeutic effect the osteoporosis due to the prolonged application adrenocortical hormone.This preparation can stop further losing of sclerotin, promotes alcium and phosphor metabolization, promotes that blood calcium is converted into bone calcium, promotes new bone formation, makes loose osseous tissue become fine and close, and can eliminate the various untoward reaction due to the osteoporosis.There is no report with this compound preparation treatment osteoporosis domestic and foreign literature.
This compound preparation can prepare by following SOME METHODS:
1. get Fructus Cnidii 30～70%, Herba Epimedii 30～70% is pulverized or powder, adds 75～95% soak with ethanol 24 hours, filters, reclaim ethanol, it is standby to get ethanol extract, and medicinal residues decoct with water 3 times again, merge three times filtrate, filter, filtrate is concentrated in right amount, add Margarita layer powder 5～10% and aforesaid ethanol extract, cold drying, pulverize, add appropriate amount of auxiliary materials, make granule, tabletting, sugar coating or encapsulated, promptly.
2. get Fructus Cnidii and be ground into powder in right amount, with 0.5% caustic lye of soda heating extraction, extracting solution neutralizes back gained precipitate again with acetone treatment with acid, the extract obtained proper proportion of pressing adds in the Herba Epimedii extractum, and adds 5～15% Margarita layer powder, concentrate drying, add appropriate amount of auxiliary materials, make the granule tabletting, sugar coating or encapsulated, promptly.
3. get Fructus Cnidii 30～70%, Herba Epimedii 30～70% is ground into Powderedly, sieves, and fine powder is standby, and coarse powder decocts with water three times, the first two times 1.5 hours, and last 1 hour, collecting decoction filters.Filtrate decompression concentrates, and adds 5 times of amounts of 85% ethanol, fully stirs, and leaves standstill 24 hours, filters, filtrate is condensed into the thick paste shape, adds above-mentioned fine powder and 5～15% Margarita layer powder, is dried to dry extract, adds appropriate amount of auxiliary materials, make granule, tabletting, sugar coating or encapsulated, promptly.
The goods that adopt above 1～3 method to make, through the pharmacology, toxicologic study proves, this product is to the osteoporosis due to the removal ovary, go the osteoporosis due to the testis, to the osteoporosis due to the prolonged application adrenocortical hormone, osteoporosis due to the ＂ insufficiency of kidney-YANG ＂ due to the hydroxyurea there are splendid prevention and therapeutical effect, acute toxicity test and long term toxicity test (comprising 3 months to 6 months) confirm that all this product toxicity is low, take for a long time the heart, liver, kidney, lung, stomach, intestinal, spleen, thymus, the all harmless effect of each vitals such as lymph node.Clinical research shows, this product is to primary osteoporosis such as menopausal women and senile osteoporosis, and the osteoporosis of secondary osteoporosis such as hypercorticalismus disease, hyperthyroidism, hyperparathyroidism and drug-induced all has good preventive and therapeutic effect.
This preparation is added some Chinese prescription, osteoporosis to following some diseases or drug-induced can obtain better therapeutic effect, promptly in protect against osteoporosis, can treat targetedly protopathy again, untoward reaction to some drugs also has the better prevention effect, is exemplified below:
One. to the optimum formula of the control of diabetic osteoporosis disease
1. fill a prescription (1):, on the basis of the basic prescription that Herba Epimedii and Margarita layer powder are formed, add Radix Ginseng 3～8% again with Fructus Cnidii; Rhizoma Coptidis 5～15%; The Rhizoma Anemarrhenae 5～15%; Cortex Moutan 5～15% and Lien Sus domestica.After the compound preparation that this prescription is made into by aforementioned technology, concentrate drying become dried cream, add Lien Sus domestica powder 5～10%, make granule, tabletting, sugar coating or encapsulated.Clinical observation shows, this preparation is better to the curative effect of the osteoporosis due to the diabetes.
2. fill a prescription (2):, on the basis of the basic prescription that Herba Epimedii and Margarita layer powder are formed, add Radix Salviae Miltiorrhizae 5～15% again with Fructus Cnidii; The Radix Astragali 5～15%:; Fructus Schisandrae Chinensis 5～15%; Radix Notoginseng 3～5%.This prescription is made compound preparation by prescription (1) described technology, and is better to the therapeutic effect of the secondary osteoporosis due to the diabetes, can prevent the generation and the development of osteoporosis at etiological treatment again.
Two. to the optimum formula of the osteoporosis due to the prolonged application glucocorticoid:
1. prescription (3): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add the Radix Astragali 5～15%; The Rhizoma Atractylodis Macrocephalae 5～15%; The Rhizoma Anemarrhenae 5～15%; Make compound preparation by aforesaid technology, said preparation and adrenocortical hormone share, but the antiinflammatory action of adrenal cortex reinforcing hormone can resist various untoward reaction, particularly osteoporosis due to the adrenocortical hormone again.
2. prescription (4): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add the Radix Rehmanniae 5～15%, Fructus Psoraleae 5～15%, Radix Aconiti Lateralis Preparata 3～5%, Radix Glycyrrhizae 3～5%.Make compound preparation by aforementioned technology, said preparation has splendid antagonism to osteoporosis and other untoward reaction due to the adrenocortical hormone.
Three. to the optimum formula of menopausal women osteoporosis:
1. prescription (5): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add Radix Salviae Miltiorrhizae 5～15%; Rhizoma Cimicifugae 5～15%; Radix Et Rhizoma Rhei 5～15%.Make compound preparation by aforementioned technology.This preparation has splendid therapeutic effect to the patient of menopausal women and senile osteoporosis.
2. prescription (6): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add Radix Ginseng 3～8%; Rhizoma Osmundae 5～15%, Rhizoma Cyperi 3～15%; Fructus Psoraleae 5～15%.Make compound preparation by aforementioned technology, this preparation has splendid therapeutic effect to the patient of menopausal women and senile osteoporosis.
Four. to the optimum formula of the osteoporosis due to the anticancer chemotherapy medicine:
1. prescription (7): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add Radix Et Caulis Acanthopanacis Senticosi 5～15%; Caulis Spatholobi 5～15%; The Radix Astragali 5～15%; Radix Angelicae Sinensis 5～15%.Make compound preparation by aforementioned technology, this preparation has antagonism preferably to the osteoporosis due to the prolonged application anticarcinogen chemotherapy and the bone marrow depression due to the chemotherapeutic and gastrointestinal reaction.
2. prescription (8): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add Fructus Ligustri Lucidi 5～15%; Rhizoma Polygoni Cuspidati 5～15%; Fructus Jujubae 5～15%; The Rhizoma Pinelliae 5～15%.Make compound preparation by aforementioned technology, this preparation to long-term with the osteoporosis due to the anticarcinogen chemotherapy and the better prevention effect of leukopenia due to the chemotherapeutic and gastrointestinal reaction.
Five. the optimum formula of the osteoporosis due to the control hyperthyroidism:
1. prescription (9): with Fructus Cnidii, Herba Epimedii and Margarita layer powder are on the basis of basis side, add Rhizoma Cimicifugae 5～15%; Radix Puerariae 5～15%; Cortex Moutan 5～15%.Make compound preparation by aforementioned technology, this preparation has fabulous preventive and therapeutic effect to the osteoporosis due to the hyperthyroidism.
Six. the optimum formula of the osteoporosis due to the control renal osteodystrophy:
1. prescription (10): with Fructus Cnidii, Herba Epimedii and Margarita layer powder be on the basis of basis side, the interpolation vitamin B
6, vitamin C and vitamin D.Make compound Chinese medicinal preparation by preceding method, every tablet or capsule include vitamin B
610～25mg, vitamin C 100～200mg, vitamin D2～30,000 IU.This prescription has preferable curative effect to the osteoporosis due to the renal osteodystrophy.
In sum, with Fructus Cnidii, the compound preparation that Herba Epimedii and Margarita layer powder are formed all has curative effect preferably to the osteoporosis due to a variety of causes, adds some other drugs on this basis, its to some specific disease because of the osteoporosis curative effect better.The proposition of this compound preparation can be the clinical treatment osteoporosis good curing articles for use is provided.
Above-mentioned preparation is through further technological transformation, can be made into injection and is used for clinically, also can be made into electuary, oral liquid, beverage, health promoting wine etc. and is used for clinical.
Claims (10)
1, a kind of by Fructus Cnidii, the Chinese medicine preparation of the treatment osteoporosis that Herba Epimedii and Margarita layer powder are formed is characterized in that containing Chinese medicine Fructus Cnidii 30～70%; Herba Epimedii 30～70%; Margarita layer powder 5～30%; This preparation alcohol extraction, decocting concentrates, and technologies such as drying are made and can be supplied oral tablet, capsule, granule or pill also can be made into injection for intramuscular injection.
2, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Radix Ginseng 3～8%; Rhizoma Coptidis 5～15%; The Rhizoma Anemarrhenae 5～15%; Cortex Moutan 5～15%; Lien Sus domestica dry powder 5～15%.
3, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Radix Salviae Miltiorrhizae 5～15%; The Radix Astragali 5～15%; Fructus Schisandrae Chinensis 5～15%; Radix Notoginseng 3～15%.
4, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain the Radix Astragali 5～15%; The Rhizoma Atractylodis Macrocephalae 5～15%; The Rhizoma Anemarrhenae 5～15%.
5, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain the Radix Rehmanniae 5～15%; Fructus Psoraleae 5～15%; Radix Aconiti Lateralis Preparata 3～5%; Radix Glycyrrhizae 3～5%.
6, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Radix Salviae Miltiorrhizae 5～15%; Rhizoma Cimicifugae 5～15%; Radix Et Rhizoma Rhei 5～15%.
7. the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Radix Ginseng 3～8%; Rhizoma Osmundae 5～15%; Rhizoma Cyperi 3～15%; Fructus Psoraleae 5～15%.
8, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Radix Et Caulis Acanthopanacis Senticosi 5～15%; Caulis Spatholobi 5～15%; The Radix Astragali 5～15%; Radix Angelicae Sinensis 5～15%, or Fructus Ligustri Lucidi 5～15%; Rhizoma Polygoni Cuspidati 5～15%; Fructus Jujubae 5～15%; The Rhizoma Pinelliae 5～15%.
9, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain Rhizoma Cimicifugae 5～15%; Radix Puerariae 5～15%; Cortex Moutan 5～15%.
10, the Chinese medicine preparation of treatment osteoporosis as claimed in claim 1 is characterized in that its optimum formula can contain vitamin B
6Vitamin C; Vitamin D.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93121565 CN1121810A (en) | 1993-12-25 | 1993-12-25 | Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93121565 CN1121810A (en) | 1993-12-25 | 1993-12-25 | Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1121810A true CN1121810A (en) | 1996-05-08 |
Family
ID=4993729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93121565 Pending CN1121810A (en) | 1993-12-25 | 1993-12-25 | Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1121810A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004089389A1 (en) * | 2003-04-11 | 2004-10-21 | Nuliv Biomedicine Inc. | Pharmaceutical composition for prevention and treatment of osteoporosis and its preparation |
| CN1313111C (en) * | 2004-05-13 | 2007-05-02 | 中国人民解放军第二军医大学 | Chinese medicinal extract for resisting osteoporosis and its preparation |
| CN101380359B (en) * | 2008-10-20 | 2011-01-12 | 浙江省中医药研究院 | Bone-building capsules and preparation method thereof |
| CN101579389B (en) * | 2008-05-15 | 2011-08-31 | 北京北大维信生物科技有限公司 | Medicinal composition for treating osteoporosis |
| CN104147073A (en) * | 2014-08-13 | 2014-11-19 | 湛江广医医药科技开发有限公司 | Traditional Chinese medicine preparation formula capable of warming kidney and invigorating yang as well as preventing and treating osteoporosis, production technology and application thereof |
| CN104547750A (en) * | 2015-01-09 | 2015-04-29 | 周恩昌 | Traditional Chinese medicine composition for treating senile osteoporosis |
| CN113332326A (en) * | 2021-06-15 | 2021-09-03 | 张家港市中医医院 | Traditional Chinese medicine composition for relieving bone marrow suppression after chemotherapy and preparation method thereof |
-
1993
- 1993-12-25 CN CN 93121565 patent/CN1121810A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004089389A1 (en) * | 2003-04-11 | 2004-10-21 | Nuliv Biomedicine Inc. | Pharmaceutical composition for prevention and treatment of osteoporosis and its preparation |
| CN1313111C (en) * | 2004-05-13 | 2007-05-02 | 中国人民解放军第二军医大学 | Chinese medicinal extract for resisting osteoporosis and its preparation |
| CN101579389B (en) * | 2008-05-15 | 2011-08-31 | 北京北大维信生物科技有限公司 | Medicinal composition for treating osteoporosis |
| CN101380359B (en) * | 2008-10-20 | 2011-01-12 | 浙江省中医药研究院 | Bone-building capsules and preparation method thereof |
| CN104147073A (en) * | 2014-08-13 | 2014-11-19 | 湛江广医医药科技开发有限公司 | Traditional Chinese medicine preparation formula capable of warming kidney and invigorating yang as well as preventing and treating osteoporosis, production technology and application thereof |
| CN104547750A (en) * | 2015-01-09 | 2015-04-29 | 周恩昌 | Traditional Chinese medicine composition for treating senile osteoporosis |
| CN113332326A (en) * | 2021-06-15 | 2021-09-03 | 张家港市中医医院 | Traditional Chinese medicine composition for relieving bone marrow suppression after chemotherapy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8747913B2 (en) | Herbal extract pharmaceutical composition and method for treating and/or preventing of hyperlipidemia and processes for producing the same | |
| CN101940630B (en) | Chinese medicinal composition for treating odontitis and preparation method thereof | |
| CN101485825A (en) | Chinese medicine capsule for treating diabetes | |
| CN1121810A (en) | Compound Chinese medicine preparation for treatment of osteoporosis and preparing process thereof | |
| CN1112010A (en) | Compound traditional Chinese medicine preparation for treatment of osteoporosis and preparing method thereof | |
| CN1843446A (en) | Combined matched pharmaceutical for treating irregular menses | |
| KR101017929B1 (en) | Anti-anal composition and process for its manufacture | |
| CN1634213A (en) | Chinese medicinal formulation for hematogenesis | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN100594918C (en) | Compound Chinese medicinal oral preparation for treating osteoporosis and preparation method thererof | |
| CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
| CN101095894A (en) | Chinese traditional medicine composition for treating myocardium disease and method of making the same | |
| CN100475248C (en) | A medicine for treating metrorrhagia and preparation process thereof | |
| CN1184995C (en) | Kidney-strengthening and pregnancy assisting granule | |
| CN1698708A (en) | Leucorrhea disease treatment capsule and its preparation method | |
| CN116139230B (en) | Traditional Chinese medicine composition for improving metabolic syndrome, preparation method and application thereof | |
| CN1989999A (en) | Preparing process of compound recipe Danshen tablet | |
| CN1211105C (en) | Anticancer syrup and its preparing process | |
| CN1149491A (en) | Traditional Chinese medicine spray preparation for curing and clearing oral peculiar smell and its making technology | |
| CN104107351A (en) | Chinese herbal medicine for blood fat reducing, and administration method thereof | |
| CN112245489A (en) | Solid beverage with turbidity eliminating and lipid lowering functions and preparation method thereof | |
| CN100348233C (en) | Preparation method of Chinese medicinal composition for treating allodromy | |
| CN1315195A (en) | Jingan shierkang capsule and its preparing process | |
| CN1119116A (en) | Medicine for curing angiocardiopathy and cerebrovascular diseases and preparing process thereof | |
| CN100522203C (en) | Medicine for treating hyperlipidemia and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication |